论文部分内容阅读
目的:探讨碘克沙醇注射液对介入治疗ST段抬高性心肌梗死患者治疗的有效性及安全性。方法:选取我院收治的介入ST段抬高性心肌梗死患者68例,根据选用的造影剂的不同,分为两组,每组各34例,其中对照组予碘普罗胺注射液,实验组予碘克沙醇注射液。治疗后,观察并比较两组患者的影像学质量,围手术期的不良反应,术前术后的肾功能情况。结果:治疗后,与对照组相比较,实验组的影像学质量明显改善(P<0.05),围手术期不良反应显著减少(P<0.05),肾功能改变不明显(P<0.05),差异均有统计学意义。结论:碘克沙醇注射液对介入ST段抬高性心肌梗死患者治疗造影效果好,对患者的肾功能影响较低,更为安全有效,值得临床推广使用。
Objective: To investigate the efficacy and safety of iodixanol injection in the treatment of patients with ST-elevation myocardial infarction. Methods: Sixty-eight patients with ST-segment elevation myocardial infarction who were treated in our hospital were selected and divided into two groups according to the choice of contrast medium. Each group consisted of 34 patients. The control group was given iopromide injection and the experimental group Give iodixargill injection. After treatment, the imaging quality, perioperative adverse reactions and preoperative and postoperative renal function were observed and compared between the two groups. Results: Compared with the control group, the imaging quality of the experimental group was significantly improved (P <0.05), the perioperative adverse reaction was significantly decreased (P <0.05), the renal function was not significantly changed (P <0.05) All have statistical significance. CONCLUSION: Iodixanol injection is effective in treating patients with ST-segment elevation myocardial infarction and has a lower impact on renal function. It is more safe and effective and worthy of clinical application.